Unified Approach to Treating Exogenous Endophthalmitis With Immediate Vitrectomy.

IF 0.5 Q4 OPHTHALMOLOGY Journal of VitreoRetinal Diseases Pub Date : 2024-09-11 DOI:10.1177/24741264241275246
Graeme K Loh, Amit V Mishra, Mark Seamone, Matthew Tennant
{"title":"Unified Approach to Treating Exogenous Endophthalmitis With Immediate Vitrectomy.","authors":"Graeme K Loh, Amit V Mishra, Mark Seamone, Matthew Tennant","doi":"10.1177/24741264241275246","DOIUrl":null,"url":null,"abstract":"<p><p><b>Purpose:</b> To analyze the outcomes and complications of immediate (within 24 hours) small-gauge (23-gauge, 25-gauge) pars plana vitrectomy (PPV) for all causes of exogenous endophthalmitis. <b>Methods:</b> A retrospective case series was evaluated. <b>Results:</b> The study included 107 patients who had immediate PPV for exogenous endophthalmitis between 2016 and 2022. The primary outcome measures were the change from baseline best-corrected visual acuity (BCVA) to the final follow-up and the complications after PPV. Causes of exogenous endophthalmitis included intravitreal injections (62.6%), PPV (18.7%), cataract surgery (11.2%), glaucoma surgery (5.6%), and trauma (1.9%). The most common complications were retinal detachment (17.8%) and secondary glaucoma (9.3%). The mean logMAR BCVA improved significantly from the initial diagnosis to the final follow-up (2.26 vs 1.21) (<i>P</i> < .0001). <b>Conclusions:</b> In most cases, immediate small-gauge vitrectomy for exogenous endophthalmitis leads to an improvement in VA, regardless of the VA at presentation. Patients should be counseled about the potential risks associated with PPV surgery.</p>","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":" ","pages":"24741264241275246"},"PeriodicalIF":0.5000,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556366/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of VitreoRetinal Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/24741264241275246","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To analyze the outcomes and complications of immediate (within 24 hours) small-gauge (23-gauge, 25-gauge) pars plana vitrectomy (PPV) for all causes of exogenous endophthalmitis. Methods: A retrospective case series was evaluated. Results: The study included 107 patients who had immediate PPV for exogenous endophthalmitis between 2016 and 2022. The primary outcome measures were the change from baseline best-corrected visual acuity (BCVA) to the final follow-up and the complications after PPV. Causes of exogenous endophthalmitis included intravitreal injections (62.6%), PPV (18.7%), cataract surgery (11.2%), glaucoma surgery (5.6%), and trauma (1.9%). The most common complications were retinal detachment (17.8%) and secondary glaucoma (9.3%). The mean logMAR BCVA improved significantly from the initial diagnosis to the final follow-up (2.26 vs 1.21) (P < .0001). Conclusions: In most cases, immediate small-gauge vitrectomy for exogenous endophthalmitis leads to an improvement in VA, regardless of the VA at presentation. Patients should be counseled about the potential risks associated with PPV surgery.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
立即进行玻璃体切割术治疗外源性眼内炎的统一方法。
目的:分析针对各种原因引起的外源性眼内炎立即(24 小时内)进行小号(23 号、25 号)玻璃体旁切除术(PPV)的结果和并发症。方法:对一个回顾性病例系列进行评估。结果:研究纳入了2016年至2022年间因外源性眼内炎而立即进行PPV手术的107例患者。主要结果指标是基线最佳矫正视力(BCVA)到最终随访的变化以及PPV后的并发症。外源性眼内炎的病因包括玻璃体内注射(62.6%)、PPV(18.7%)、白内障手术(11.2%)、青光眼手术(5.6%)和外伤(1.9%)。最常见的并发症是视网膜脱离(17.8%)和继发性青光眼(9.3%)。从最初诊断到最后随访,BCVA的平均logMAR值明显改善(2.26 vs 1.21)(P 结论:从最初诊断到最后随访,BCVA的平均logMAR值明显改善(2.26 vs 1.21):在大多数情况下,无论患者发病时的视力如何,立即进行小号玻璃体切割术治疗外源性眼内炎都能改善视力。应告知患者 PPV 手术的潜在风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.20
自引率
16.70%
发文量
0
期刊最新文献
Clinical Profiles of Retinal Vasoproliferative Tumors. Serpiginous Choroiditis After COVID-19 Infection. Ischemic Retinopathy Associated With Mantle Cell Lymphoma-Induced Vascular Occlusion. Antivascular Endothelial Growth Factor Injections for the Chronic Treatment of Macula-off, Fovea-on Diabetic Tractional Retinal Detachment With Vitreous Hemorrhage. Exudative Vitreoretinopathy With a Coats-Like Response in Poretti-Boltshauser Syndrome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1